False
Advertisement
The Burden of Proof
March 13, 2020
The glaucoma subspecialty is now at a turning point. But new approaches, including MIGS, must be based on high-quality evidence – and that means more randomized controlled trials.
1 min read
Newsletters
Receive the latest Ophthalmology news, personalities, education, and career development – weekly to your inbox.
False
Advertisement